title: -Value of activated blood coagulation time in monitoring anticoagulation during coronary angioplasty-.
abstract: Accurate heparin anticoagulation assessment is important to prevent complications (hemorrhage, thrombotic coronary occlusion) during and after coronary angioplasty (PTCA). Paired ACT-, aPTT- and prothrombin time (PT) measurements have not been studied after PTCA using a high dose heparin management. For that reason we analyzed in 150 consecutive patients (115 m., 35 f., 61 +/- 10 y.) immediately after PTCA and at the time of arterial sheath removal aPTT-(Neothromtin, Behring), PT- (Thromborel S, Behring) and ACT-(HR-ACT, HemoTec) values after application of 20,000 U of heparin (5,000 U intravenous, 15,000 U intracoronary) followed by a heparin-infusion (15,000-25,000 U/24 h). Immediately after PTCA in all patients a aPTT above the upper limit of >180 s was found. The average postprocedural ACT was 330 +/- 82 s. Only 9 patients showed an ACT below 200 s. All coronary reocclusions (n = 3) immediately after PTCA occurred in this group. Arterial sheaths were removed 13 +/- 3 h after PTCA. The incidence of minor peripheral bleeding complications at that time was 21% and was related to the anticoagulation level. Major bleeding complications requiring transfusion were noted in only one case. Our findings suggest that after high dose heparinization for PTCA the ACT test provides a reliable and broad range for the assessment of heparin anticoagulation. In contrast to the aPTT the ACT is ideally suited to determine the dosage of heparin infusion and the time of arterial sheath removal after PTCA. ACT measurements are superior to aPTT measurements in heparin anticoagulation assessment during and direct after PTCA.
authors.affiliation: Medizinische Klinik B, Kardiologie Herzzentrum Wuppertal Universität Witten-Herdecke.
authors.forename: M
authors.initials: M
authors.lastname: Kunert
authors.forename: R
authors.initials: R
authors.lastname: Sorgenicht
authors.forename: L
authors.initials: L
authors.lastname: Scheuble
authors.forename: T
authors.initials: T
authors.lastname: Ketteler
authors.forename: E
authors.initials: E
authors.lastname: Lürken
authors.forename: I
authors.initials: I
authors.lastname: Meyer
authors.forename: A
authors.initials: A
authors.lastname: Müller
authors.forename: K
authors.initials: K
authors.lastname: Emmerich
authors.forename: H
authors.initials: H
authors.lastname: Gülker
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D003324:Coronary Artery Disease / Q000097:blood / Q000628:therapy*; D003328:Coronary Thrombosis / Q000097:blood / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D005260:Female; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D012008:Recurrence; D012016:Reference Values; D014914:Whole Blood Coagulation Time
chemical_list: D006493:Heparin
vernacular_title: Der Stellenwert der aktivierten Gerinnungszeit (ACT) in der Uberwachung der Antikoagulation bei Koronarangioplastie.